VEGFA and rheumatoid arthritis: Many anti-rheumatic drugs used clinically affect the vascular structure; cyclosporine A has recently been shown to inhibit endothelial cell migration and angiogenesis induced by VEGF, which may be a new mechanism of cyclosporine A in the treatment of RA [20,31].